stars 1 stars 2 stars 3

Glycominds, a commercial stage diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease biomarkers with a distinctive focus on the Inflammatory Bowel Disease (IBD).

Glycominds, LLC Questions

The Glycominds, LLC annual revenue was $5 million in 2026.

Glycominds, LLC is based in Simi Valley, California.

The NAICS codes for Glycominds, LLC are [325, 3254, 32541, 325413, 32].

The SIC codes for Glycominds, LLC are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users